Evaluation of health related quality of life in patients with metabolic syndrome

dc.contributor.author	Τζιάλλας, Δημήτριος	el
dc.contributor.author	Καστανιώτη, Κατερίνα Κ.	el
dc.contributor.author	Σάββας, Κώστας	el
dc.contributor.author	Κωσταπάνος, Μιχαήλ Σ.	el
dc.contributor.author	Τζιάλλας, Βασίλειος	el
dc.date.accessioned	2014-07-15T20:24:13Z
dc.date.available	2014-07-15T20:24:13Z
dc.date.issued	2014-07-15
dc.identifier.uri	http://hdl.handle.net/11400/1334
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	www.hsj.gr	en
dc.subject	Metabolic syndrome
dc.subject	Cardiovascular system--Diseases--Nursing
dc.subject	Υγεία σχετιζόμενη με την ποιότητα ζωής
dc.subject	Καρδιαγγειακή νόσος
dc.subject	Κατάθλιψη
dc.subject	Health related quality of life
dc.subject	Depression
dc.title	Evaluation of health related quality of life in patients with metabolic syndrome	en
heal.type	journalArticle
heal.classification	Medicine
heal.classification	Ιατρική
heal.classification	Metabolic Syndrome
heal.classification	Μεταβολικές διαταραχές
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI	N/A-Ιατρική
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh2005005763
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh85020224
heal.contributorName	Σκαπινάκης, Πέτρος	el
heal.contributorName	Ελισάφ, Μωησής Σ.	el
heal.contributorName	Βενετσάνος, Μαυρέας	el
heal.language	en
heal.access	free
heal.recordProvider	Τεχνολογικό Εκπαιδευτικό Ίδρυμα Αθήνας.Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Νοσηλευτικής	el
heal.publicationDate	2012-03
heal.bibliographicCitation	Tziallas, D., Kastanioti, C., Kostas, S., Kostapanos, M.S., Tziallas, V., Skapinakis, P., Elisaf, M.S., Mavreas, V. (2012) Evaluation of health related quality of life in patients with metabolic syndrome. "Health Science Journal". 6 (1). p. 115-27.	en
heal.abstract	Background: Metabolic syndrome [MetSyn] is a combination of physiological risk factors that can trigger physical and emotional problems. The aim of this study is to investigate whether MetS is associated with lower health related quality of life (HRQoL) and depression. Methods: New consecutive patients referred to an outpatient lipid clinic for evaluation of possible MetSyn were eligible for inclusion in the study. The MetSyn was defined according to the International Diabetes Federation (IDF) diagnostic criteria. The Medical Outcomes Study, Short Form-36 (SF-36) was used to assess HRQoL. Anxiety and depressive symptoms were assessed by a validated Greek version of the Hospital Anxiety and Depression Scale (HADS). Multivariate regressions were used to assess the hypothesis. Results: Three hundred and fifty-nine subjects were involved of whom 206 [57.4%] met the diagnostic criteria for the MetSyn (“cases”) and 153 [42.6%] did not (“comparator group”). Comparisons of SF-36 scores between patients with and without MetSyn revealed statistically significance differences except of bodily pain subscale [Physical Functioning: 78.4 vs 87.8, Role Physical: 66.8 vs 85.5; General Health: 59.8 vs 70.4; Vitality: 59.6 vs 68.0; Social Functioning: 76.5 vs 83.8; Role Emotional: 69.3 vs 82.6, Mental Health: 60.8 vs 71.7]. A predominance of anxiety [60%] and depressive symptoms [67%] was observed among subjects with MetSyn. Patients with MetSyn undergoing a therapeutic approach showed no improvement in its general and mental health [p: NS]. Conclusions: The presence of MetSyn was associated with more impaired HRQoL as well as depressive behaviours.	en
heal.publisher	Μαρβάκη, Χριστίνα	el
heal.journalName	Health Science Journal	en
heal.journalType	peer-reviewed
heal.fullTextAvailability	true
heal.dateCreated	2012-01
heal.classificationURI.other	http://catdir.loc.gov/catdir/toc/ecip0620/2006028578.html